Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism [1]

JAMA

Volumn 304, Issue 22, 2010, Pages 2481-

  Rotondi, Mario ^a   Magri, Flavia ^a   Chiovato, Luca ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY; THYROTROPIN;

BODY MASS; DISEASE ASSOCIATION; HUMAN; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; LETTER; MORTALITY; OBESITY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

EID: 78649843298     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1786     Document Type: Letter

References (5)

1. Rodondi N, den Elzen WP, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
2. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 2006;91(8):3088-3091. (Pubitemid 44271761)
3. Rotondi M, Leporati P, La Manna A, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol. 2009;160(3):403-408.
4. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316(2):165-171.
5. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76-131. (Pubitemid 351252748)